13 research outputs found
Simulation Training to Improve Informed Consent and Pharmacokinetic/Pharmacodynamic Sampling in Pediatric Trials
Get PDFPharmacotherapeutic management of paediatric heart failure and ACE-I use patterns: A European survey
Get PDFObjective To characterise heart failure (HF) maintenance
pharmacotherapy for children across Europe and
investigate how angiotensin-converting enzyme inhibitors
(ACE-I) are used in this setting.
Methods A Europe-wide web-based survey was
conducted between January and May 2015 among
European paediatricians dedicated to cardiology.
Results Out of 200-eligible, 100 physicians representing
100 hospitals in 27 European countries participated. All
participants reported prescribing ACE-I to treat dilated
cardiomyopathy-related HF and 97% in the context of
congenital heart defects; 87% for single ventricle physiology.
Twenty-six per cent avoid ACE-I i
Physiologically Based Pharmacokinetic Models in the Prediction of Oral Drug Exposure Over the Entire Pediatric Age Range—Sotalol as a Model Drug
Get PDFEvidenzbasierte Leitlinien fĂĽr die Selbstmedikation: Anforderungen der Pharmazeuten fĂĽr den Apothekenalltag
No full textEffect of transient reduction of cerebral blood flow in normotensive rats on striatal dopamine release
No full text
Pharmacotherapeutic management of paediatric heart failure and ACE-I use patterns: A European survey
No full textA Modeling and Simulations Framework to Support Global Regulatory Strategies for Pediatric Drug Development Programs
No full textOff-label drug use among hospitalised children: identifying areas with the highest need for research
No full text
